Advertisement

Real-time determination of gastric juice pH with EndoFaster® for atrophic gastritis assessment

      Abstract

      Background

      In patients with atrophic gastritis involving gastric body mucosa the pH value of gastric juice is distinctly increased, so that pH assessment would allow predict this precancerous lesion. We tested whether EndoFaster® − a device allowing real-time pH measure and H. pylori diagnosis – may optimize the need of taking gastric biopsies.

      Methods

      In this prospective, multicentre study, the accuracy of EndoFaster® for ruling out gastric atrophy involving corporal mucosa was assessed. Real-time pH and ammonium determination was performed by aspirating 3–6 ml gastric juice during endoscopy. Histology performed on 5 standard gastric biopsies was used as gold standard.

      Results

      A total of 1008 consecutive patients were observed in 12 centres. At histology, gastric body mucosa atrophy/metaplasia was detected in 65 (6.4%) cases, and a pH value >4.5 in the gastric juice was observed in 150 patients. The values of EndoFaster® performance in predicting the presence of atrophic gastritis were as follow: 51% sensitivity, 84% specificity, 18% PPV, 96% NPV, and 82% accuracy. The NPV value was not distinctly affected by neither ongoing proton pump inhibitor therapy nor H. pylori infection. By considering also data of ammonium concentrations, the values of EndoFaster® in detecting extensive atrophy on gastric mucosa were 74% sensitivity, 84% specificity, 24% PPV, 98% NPV, and 83% accuracy.

      Conclusion

      The very high NPV of EndoFaster® might allow to safely rule out presence of atrophic gastritis, reducing the need of taking gastric biopsies in unselected patients managed in clinical practice

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Buscarini E.
        • Conte D.
        • Cannizzaro R.
        • et al.
        White paper of Italian gastroenterology: delivery of services for digestive diseases in Italy: weaknesses and strengths.
        Dig Liver Dis. 2014; 46: 579-589
        • Peery A.F.
        • Dellon E.S.
        • Lund J.
        • et al.
        Burden of gastrointestinal disease in the United States: 2012 update.
        Gastroenterology. 2012; 143: 1179-1187
        • Shenbagaraj L.
        • Thomas-Gibson S.
        • Stebbing J.
        • et al.
        Endoscopy in 2017: a national survey of practice in the UK.
        Frontline Gastroenterol. 2019; 10: 7-15
        • Pimentel-Nunes P.
        • Libânio D.
        • Marcos-Pinto R.
        • et al.
        Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), European helicobacter and microbiota study group (EHMSG), European society of pathology (ESP), and Sociedade Portuguesa de endoscopia digestiva (SPED) guideline update 2019.
        Endoscopy. 2019; 51: 365-388
        • Rugge M.
        • Pennelli G.
        • Pilozzi E.
        • et al.
        Gastritis: the histology report.
        Dig Liver Dis. 2011; 43: S373-S384
        • Capelle L.G.
        • de Vries A.C.
        • Haringsma J.
        • et al.
        The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
        Gastrointest Endosc. 2010; 71: 1150-1158
        • Lahner E.
        • Zagari R.M.
        • Zullo A.
        • et al.
        Chronic atrophic gastritis: natural history, diagnosis and therapeutic management. A position paper by the Italian society of hospital gastroenterologists and digestive endoscopists [AIGO], the Italian society of digestive endoscopy [SIED], the Italian society of gastroenterology [SIGE], and the Italian society of internal medicine [SIMI].
        Dig Liver Dis. 2019; 51: 1621-1632
        • Lahner E.
        • Hassan C.
        • Esposito G.
        • et al.
        Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: a low-risk country.
        Dig Liver Dis. 2017; 49: 291-296
        • Esposito G.
        • Dilaghi E.
        • Cazzato M.
        • et al.
        Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region.
        Dig Liver Dis. 2021; 53: 467-473
        • Lahner E.
        • Carabotti M.
        • Esposito G.
        • et al.
        Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms.
        Eur J Gastroenterol Hepatol. 2018; 30: 1291-1296
        • Rugge M.
        • Meggio A.
        • Pravadelli C.
        • et al.
        Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
        Gut. 2019; 68: 11-17
        • Rugge M.
        • Genta R.M.
        • Fassan M.
        • et al.
        OLGA Gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients.
        Am J Gastroenterol. 2018; 113: 1621-1628
        • Lu P.J.
        • Hsu P.I.
        • Chen C.H.
        • et al.
        Gastric juice acidity in upper gastrointestinal diseases.
        World J Gastroenterol. 2010; 16: 5496-5501
        • Neumann W.L.
        • Coss E.
        • Rugge M.
        • et al.
        Autoimmune atrophic gastritis - pathogenesis, pathology and management.
        Nat Rev Gastroenterol Hepatol. 2013; 10: 529-541
        • Tucci A.
        • Tucci P.
        • Bisceglia M.
        • et al.
        Real-time detection of Helicobacter pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopy.
        Endoscopy. 2005; 37: 966-976
        • Tucci A.
        • Bisceglia M.
        • Rugge M.
        • et al.
        Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone.
        Gastrointest Endosc. 2007; 66: 881-890
        • Cazzato M.
        • Esposito G.
        • Galli G.
        • et al.
        Diagnostic accuracy of EndoFaster® and narrow-band imaging endoscopy in patients with impaired gastric acid secretion: a real-time prospective study.
        Gastroenterol Res Pract. 2021; 2021 (Mar 20)6616334
        • Costamagna G.
        • Zullo A.
        • Bizzotto A.
        • et al.
        Real-time diagnosis of H. pylori infection during endoscopy: accuracy of an innovative tool (EndoFaster).
        UEG J. 2015; 4: 339-342
        • Zullo A.
        • Germanà B.
        • Galliani E.
        • et al.
        Optimizing the searching for H. pylori in clinical practice with EndoFaster.
        Dig Liver Dis. 2021; 53: 772-775
        • Zullo A.
        • Manta R.
        • De Francesco V.
        • et al.
        Diagnostic yield of upper endoscopy according to appropriateness: a systematic review.
        Dig Liver Dis. 2019; 51: 335-339
        • Zullo A.
        • Fiorini G.
        • Bassotti G.
        • et al.
        Upper endoscopy in patients with extra-oesophageal reflux symptoms: a multicentre study.
        GE Port J Gastroenterol. 2020; 27: 312-317
        • de Vries A.C.
        • Haringsma J.
        • de Vries R.A.
        • et al.
        Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions.
        Helicobacter. 2010; 15: 259-264
        • Fitzgerald R.
        • Smith S.M.
        An overview of Helicobacter pylori infection.
        Methods Mol Biol. 2021; 2283: 1-14
      1. Italian Ministry of Health Altems. HTA endofaster: strumento Automatico di Endoscopia Chimica. https://altems.unicatt.it/altems-Mini_HTA_Strumento_Automatico_di_endoscopia_chimica.pdf.